Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GEN

Genesis Healthcare (GEN) Stock Price, News & Analysis

Genesis Healthcare logo

About Genesis Healthcare Stock (NYSE:GEN)

Advanced Chart

Key Stats

Today's Range
$29.85
$30.73
50-Day Range
$0.18
$0.60
52-Week Range
$0.40
$1.37
Volume
2.91 million shs
Average Volume
4.10 million shs
Market Capitalization
$19.49 billion
P/E Ratio
33.88
Dividend Yield
1.64%
Price Target
$33.25
Consensus Rating
Moderate Buy

Company Overview

Genesis Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

GEN MarketRank™: 

Genesis Healthcare scored higher than 15% of companies evaluated by MarketBeat, and ranked 265th out of 300 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genesis Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Genesis Healthcare has received no research coverage in the past 90 days.

  • Read more about Genesis Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genesis Healthcare is 33.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genesis Healthcare is 33.88, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 28.95.

  • Short Interest

    There is no current short interest data available for GEN.
  • Dividend Yield

    Genesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genesis Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.

  • Read more about Genesis Healthcare's dividend.
  • Short Interest

    There is no current short interest data available for GEN.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Genesis Healthcare this week, compared to 3 articles on an average week.
  • Search Interest

    5 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genesis Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.30% of the stock of Genesis Healthcare is held by insiders.

  • Percentage Held by Institutions

    82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genesis Healthcare's insider trading history.
Receive GEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

GEN Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

GEN Stock Analysis - Frequently Asked Questions

Genesis Healthcare, Inc. (NYSE:GEN) released its earnings results on Thursday, August, 1st. The company reported $0.53 earnings per share for the quarter, meeting analysts' consensus estimates of $0.53. The company's revenue was up 2.3% compared to the same quarter last year.

Genesis Healthcare's board initiated a share repurchase program on Thursday, May 9th 2024, which permits the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 23.1% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/01/2024
Today
7/05/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NYSE:GEN
Previous Symbol
NYSE:SKH
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.25
High Stock Price Target
$37.00
Low Stock Price Target
$30.00
Potential Upside/Downside
+9.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
33.88
Forward P/E Ratio
18.71
P/E Growth
N/A
Net Income
$836 million
Pretax Margin
23.69%

Debt

Sales & Book Value

Annual Sales
$2.80 billion
Cash Flow
$3.62 per share
Price / Cash Flow
8.42
Book Value
($0.16) per share
Price / Book
-190.56

Miscellaneous

Free Float
618,038,000
Market Cap
$19.49 billion
Optionable
Optionable
Beta
0.84
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:GEN) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners